165 related articles for article (PubMed ID: 25203738)
1. Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patients.
Sunakawa Y; Wakatsuki T; Yang D; Zhang W; Ning Y; Stintzing S; Stremitzer S; Yamauchi S; Sebio A; El-khoueiry R; Iqbal S; Barzi A; Gerger A; Stotz M; Azuma M; Watanabe M; Koizumi W; Lenz HJ
Pharmacogenet Genomics; 2014 Dec; 24(12):588-96. PubMed ID: 25203738
[TBL] [Abstract][Full Text] [Related]
2. Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer.
Sunakawa Y; Stremitzer S; Cao S; Zhang W; Yang D; Wakatsuki T; Ning Y; Yamauchi S; Stintzing S; Sebio A; El-Khoueiry R; Matsusaka S; Parekh A; Barzi A; Azuma M; Watanabe M; Koizumi W; Lenz HJ
Ann Oncol; 2015 Feb; 26(2):332-9. PubMed ID: 25411415
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas.
Nakajima M; Sawada H; Yamada Y; Watanabe A; Tatsumi M; Yamashita J; Matsuda M; Sakaguchi T; Hirao T; Nakano H
Cancer; 1999 May; 85(9):1894-902. PubMed ID: 10223227
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of lemur tyrosine kinase-3 germline polymorphisms in adjuvant gastric cancer in Japan and the United States.
Wakatsuki T; LaBonte MJ; Bohanes PO; Zhang W; Yang D; Azuma M; Barzi A; Ning Y; Loupakis F; Saadat S; Volz N; Stintzing S; El-Khoueiry R; Koizumi W; Watanabe M; Shah M; Stebbing J; Giamas G; Lenz HJ
Mol Cancer Ther; 2013 Oct; 12(10):2261-72. PubMed ID: 23918832
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
[TBL] [Abstract][Full Text] [Related]
6. MET amplification is not rare and predicts unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy.
An X; Wang F; Shao Q; Wang FH; Wang ZQ; Wang ZQ; Chen C; Li C; Luo HY; Zhang DS; Xu RH; Li YH
Cancer; 2014 Mar; 120(5):675-82. PubMed ID: 24804300
[TBL] [Abstract][Full Text] [Related]
7. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis.
Peng Z; Zhu Y; Wang Q; Gao J; Li Y; Li Y; Ge S; Shen L
PLoS One; 2014; 9(1):e84502. PubMed ID: 24416238
[TBL] [Abstract][Full Text] [Related]
9. C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis.
Yu S; Yu Y; Zhao N; Cui J; Li W; Liu T
PLoS One; 2013; 8(11):e79137. PubMed ID: 24223894
[TBL] [Abstract][Full Text] [Related]
10. The relationship of vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer.
Oh SY; Kwon HC; Kim SH; Lee S; Lee JH; Hwang JA; Hong SH; Graves CA; Camphausen K; Kim HJ; Lee YS
BMC Cancer; 2013 Feb; 13():43. PubMed ID: 23374220
[TBL] [Abstract][Full Text] [Related]
11. MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.
Zhang J; Guo L; Liu X; Li W; Ying J
Oncotarget; 2017 Feb; 8(6):10264-10273. PubMed ID: 28052014
[TBL] [Abstract][Full Text] [Related]
12. Volumetric parameters on
Liu G; Hu Y; Cheng X; Wang Y; Gu Y; Liu T; Shi H
BMC Cancer; 2019 Aug; 19(1):790. PubMed ID: 31395059
[TBL] [Abstract][Full Text] [Related]
13. Gastric cancer patient with c-MET amplification treated with crizotinib after failed multi-line treatment: A case report and literature review.
Hou GX; Song BB
Math Biosci Eng; 2019 Jun; 16(5):5923-5930. PubMed ID: 31499745
[TBL] [Abstract][Full Text] [Related]
14. Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target.
Lee J; Seo JW; Jun HJ; Ki CS; Park SH; Park YS; Lim HY; Choi MG; Bae JM; Sohn TS; Noh JH; Kim S; Jang HL; Kim JY; Kim KM; Kang WK; Park JO
Oncol Rep; 2011 Jun; 25(6):1517-24. PubMed ID: 21424128
[TBL] [Abstract][Full Text] [Related]
15. A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction.
Shah MA; Cho JY; Tan IB; Tebbutt NC; Yen CJ; Kang A; Shames DS; Bu L; Kang YK
Oncologist; 2016 Sep; 21(9):1085-90. PubMed ID: 27401892
[TBL] [Abstract][Full Text] [Related]
16. INC280 inhibits Wnt/β-catenin and EMT signaling pathways and its induce apoptosis in diffuse gastric cancer positive for c-MET amplification.
Sohn SH; Kim B; Sul HJ; Kim YJ; Kim HS; Kim H; Seo JB; Koh Y; Zang DY
BMC Res Notes; 2019 Mar; 12(1):125. PubMed ID: 30871613
[TBL] [Abstract][Full Text] [Related]
17. Genetic activation of the MET pathway and prognosis of patients with high-risk, radically resected gastric cancer.
Graziano F; Galluccio N; Lorenzini P; Ruzzo A; Canestrari E; D'Emidio S; Catalano V; Sisti V; Ligorio C; Andreoni F; Rulli E; Di Oto E; Fiorentini G; Zingaretti C; De Nictolis M; Cappuzzo F; Magnani M
J Clin Oncol; 2011 Dec; 29(36):4789-95. PubMed ID: 22042954
[TBL] [Abstract][Full Text] [Related]
18. MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
Catenacci DV; Ang A; Liao WL; Shen J; O'Day E; Loberg RD; Cecchi F; Hembrough T; Ruzzo A; Graziano F
Cancer; 2017 May; 123(6):1061-1070. PubMed ID: 27926778
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the c-met protooncogene in human gastric carcinoma--correlation to clinical features.
Huang TJ; Wang JY; Lin SR; Lian ST; Hsieh JS
Acta Oncol; 2001; 40(5):638-43. PubMed ID: 11669338
[TBL] [Abstract][Full Text] [Related]
20. MET expression and amplification in patients with localized gastric cancer.
Janjigian YY; Tang LH; Coit DG; Kelsen DP; Francone TD; Weiser MR; Jhanwar SC; Shah MA
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1021-7. PubMed ID: 21393565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]